Pharma Research takes all allegations of research and publication misconduct seriously and handles them using the flowcharts of the Committee on Publication Ethics (COPE).

What counts as misconduct

• Plagiarism, including self-plagiarism and duplicate publication
• Fabrication or falsification of data or images
• Undeclared conflicts of interest
• Authorship disputes, ghost or gift authorship
• Manipulation of peer review or citations
• Research done without the required ethical approval

How allegations are handled

Concerns can be raised by anyone, in confidence, at Info@s-epub.in. The editor reviews the evidence, asks the authors to respond and, where needed, contacts their institution.

Possible sanctions

• Rejection of the manuscript, or a correction, expression of concern or retraction of a published article
• A ban on submissions from the authors for a set period
• Notifying the authors' institution or funder